Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : GlaxoSmithKline Research & Development Limited
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage Parkinson’s Disease
To characterize the dose response of fixed doses of ropinirole PR as monotherapy in patients with early stage Parkinson’s disease.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
A Phase I/II, Open-Label, Multicenter, Two-Arm, Feasibility Study of Pazopanib, Carboplatin, and Paclitaxel in Women with Newly Diagnosed, Previously Untreated, Gynaecological Tumors
The primary objective of this study is to verify the safety and tolerability of treatment with daily pazopanib added to two regimens of paclitaxel and carboplatin in women with previously untreated, a...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
An open label, multicenter, Phase I/II study of pazopanib in combination with paclitaxel in first line treatment of subjects with stage IIIBwet/IV non-small cell lung cancer
Phase I: To assess the safety and tolerability and to determine the maximum tolerated regimen of pazopanib in combiantion with paclitaxel in subjects with previously untreated advanced solid tumours, ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
An open-label, single-arm, multi-center phase 2 trial with ofatumumab in patients with relapsed Diffuse Large B-Cell Lymphoma (DLBCL) ineligible for transplant or relapsed after autologous transplant
To investigate the efficacy of ofatumumab in patients with relapsed/progressive DLBCL ineligible for transplant or relapsed/progression after autologous transplant
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
A Study to Validate Key Therapeutic Targets and Biomarkers during Allergen Exposure in Subjects with Allergic Rhinitis
•To examine the change in expression of key allergy targets in the nose following exposure to allergen. •To evaluate the effect of intranasal corticosteroids treatment on the change in target expressi...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
The purpose of this study is to monitor the safety of the medications used in the preterm labor study by collecting information on the health and development of the child after child’s mother participated in a retosiban study for preterm labor during the child’s mother’s pregnancy
The study objective is to assess the safety and outcomes in infants who were exposed to retosiban or comparator in the Phase III treatment studiess. Specific objectives include the following: •To c...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
A long term clinical study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes
To determine whether albiglutide is non-inferior with respect to MACE when added to glycaemic standard of care versus standard of care alone.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 4 ans
A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer
The primary objective for this study is to evaluate and compare disease-free survival (DFS) in women treated with lapatinib versus placebo.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persistent Asthma
To determine the efficacy and dose response of repeat inhaled doses of GW870086X once daily after 28 days on FEV1 in mild to moderate asthmatics, compared with placebo
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Limited
MAJ Il y a 5 ans
A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Comparing the Efficacy and Safety of GW597599/Paroxetine combination or Paroxetine monotherapy to Placebo in Patients with Social Anxiety Disorder (SAD)
To evaluate the anxiolytic efficacy of GW597599/Paroxetine combination (15 mg and 7.5 mg, respectively/day) compared to placebo in outpatients with SAD.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
7
8
9
10
Suivant